Evidence review
How to Inject GLP-1 Medications: Sites, Rotation and Timing
Where the FDA-approved instructions say to inject Wegovy or Zepbound, how to rotate sites correctly, and the timing rules for a weekly dose.
On this page
The Desk's #1 pick
CoreAge Rx
AThe Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
Check availability- Semaglutide
- $149/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Access
- Compounded
Advertising disclosure · we may earn a commission at no extra cost to you. It never changes what we write about a product — an unflattering finding on a paying provider stays in.
Also on the board
Strut Health
B+The same molecule as a lozenge or an injection at the same price — the only place on this board where the needle is genuinely optional.
Check Strut Health availabilityWeekly self-injection is the single biggest reason people hesitate to start a GLP-1 drug, and most of that hesitation is about not knowing the mechanics. The FDA-approved prescribing information for Wegovy and Zepbound is specific about where, how and when — this is that information, not general injection advice.
Where to inject
Both drugs are approved for subcutaneous (under-the-skin, not muscle) injection in the same three areas: the abdomen, the front of the thigh, or the back of the upper arm. If injecting the abdomen, stay at least 2 inches from the navel. The back of the upper arm is difficult to self-inject accurately and is generally the site a caregiver or partner administers rather than the patient. The FDA labeling for both drugs states there is no clinically meaningful difference in absorption between the three approved sites when proper technique is used — so site choice is about comfort and access, not efficacy.
Rotating sites correctly
The instructions call for rotating the injection site each week — not necessarily to a different body area, but to a different exact spot within it. Using the abdomen every week is fine as long as you are not injecting the same square inch repeatedly. Skin that is tender, bruised, scarred, damaged, pitted, thickened or lumpy should be avoided regardless of which area it's in — those are signs of tissue that hasn't recovered from a previous injection or isn't suited for one.
Timing: same day, once a week
Both drugs are dosed once weekly, on the same day each week, with or without food, at any time of day. If you need to change your chosen day, both labels allow it as long as the minimum spacing rule for that drug is respected — see the missed-dose rules below, which are really the same spacing rule read from the other direction.
If a dose is late
- **Wegovy:** at least 48 hours must separate any two injections. Take a late dose as soon as you remember if your next scheduled one is more than 48 hours away; otherwise skip it and resume your normal day. - **Zepbound:** you have up to 4 days (96 hours) to take a late dose. Beyond that, skip it. Never take two Zepbound doses within 3 days (72 hours) of each other.
The full escalation schedule both drugs follow before reaching these weekly maintenance doses is in GLP-1 dosage and titration schedules.
Storage and pen handling
Both pens are shipped and stored refrigerated, and both labels allow a defined period at room temperature once removed from the fridge — check the specific number of days on the pen's own package insert, since it has changed across label revisions and differs slightly by product. Never inject through clothing, and inspect the medication through the pen's viewing window before injecting; both labels direct patients not to use a pen if the liquid looks cloudy, discolored, or contains particles.
When this becomes a provider question, not a technique one
Persistent injection-site pain, spreading redness, or a lump that doesn't resolve after a couple of weeks is a reason to contact your provider rather than switch injection sites and hope. For the drug's broader side-effect picture beyond the injection site itself, see GLP-1 side effects. And if the needle itself — not the schedule or the technique — is the real barrier, injections vs oral GLP-1 covers what changes and what evidence you give up by switching to a needle-free route.
Frequently asked questions
Where do I inject Wegovy or Zepbound?
The FDA-approved sites for both are the abdomen (at least 2 inches from the navel), the front of the thigh, or the back of the upper arm. There is no meaningful absorption difference between the three when injected correctly.
Do I need to rotate injection sites?
Yes — rotate to a different exact spot each week, whether or not you stay in the same general body area. Avoid any skin that is tender, bruised, scarred, or lumpy from a previous injection.
What if I forget my weekly dose?
Wegovy requires at least 48 hours between doses — take a late one if your next is more than 48 hours out, otherwise skip it. Zepbound allows up to 4 days late, and doses must never be taken within 3 days of each other.
Can someone else give me the injection?
Yes, and the back-of-the-upper-arm site specifically is generally intended to be administered by another person rather than self-injected, since it's difficult to reach accurately on yourself.
References
- U.S. Food and Drug Administration (2021). Wegovy (semaglutide) injection — Prescribing Information. Drugs@FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
- U.S. Food and Drug Administration (2023). Zepbound (tirzepatide) injection — Prescribing Information. Drugs@FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Compounded vs Brand-Name GLP-1: How to Read the Trade-Off
Brand-name Wegovy and Zepbound are FDA-approved; compounded GLP-1 is not. Here is what that difference actually means for cost, access and safety.
ReadGLP-1 and Hair Loss: What Causes It, and When It Stops
Hair thinning is not on the Wegovy or Zepbound label, but it is widely reported and increasingly studied — the mechanism, timing and who is affected.
ReadGLP-1 Dosage and Titration Schedules: Semaglutide and Tirzepatide
The FDA-approved dose-escalation steps for Wegovy and Zepbound, why the climb is slow by design, and what happens if you miss a week.
ReadOzempic vs Wegovy: Same Drug, Two Different FDA Approvals
Ozempic and Wegovy are both semaglutide. What differs is the FDA-approved indication, the maximum dose, and a cardiovascular-risk claim only one carries.
ReadInjections vs Oral or Sublingual GLP-1: What to Know
Weekly injections carry the trial-grade weight-loss evidence; oral and sublingual GLP-1 trade some data for convenience. How to weigh the route.
ReadIs Compounded GLP-1 Legit and Safe?
Compounded GLP-1 is legal but not FDA-approved. What 503A and 503B mean, why LegitScript verification matters, and how to vet a compounder before you buy.
Read